相关实验视频

Updated: May 30, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

CD47是一种瘤细胞衍生的外体特征,调节瘤免疫微环境和免疫疗法反应

Yifei Luan¹, Yinghui Zhang², Shangjin Li²

¹School of Innovation and Entrepreneurship, Hangzhou Medical College, Hangzhou 310053, PR China.

Translational oncology

|January 26, 2025

概括

CD47是瘤衍生的外体的标记物,可以区分免疫热和冷瘤,并预测卵巢和其他癌症的免疫治疗反应. 高CD47表达与更好的治疗结果和炎症瘤微环境相关.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
异构体生物学异构体生物学

背景情况:

卵巢癌 (OvCa) 的发病过程复杂,涉及遗传,环境和荷尔蒙因素.
瘤微环境 (TME) 免疫学受到外体的影响,特别是瘤衍生外体 (TEXs).
识别区分免疫热和冷瘤的TEX对于预测免疫疗法反应至关重要.

研究的目的:

为了确定能够区分免疫热和免疫冷瘤的瘤衍生外体 (TEXs).
评估TEXs作为生物标志物的潜力,用于预测上皮细胞癌中的免疫治疗反应.
调查CD47表达在卵巢和其他上皮细胞癌的免疫相关性.

主要方法:

对CD47表达模式和免疫相关性进行了转录和单细胞RNA测序 (scRNA-seq) 数据集的分析.
一个全妇科癌症队列被用来验证CD47与炎症TME的相关性.
分析了免疫治疗队列,以评估CD47表达和治疗敏感性之间的关联.

主要成果:

CD47被确定为TEX签名,在不同的临床病理特征中没有显著的转录差异.
CD47表达与免疫信号通路和OvCa.免疫细胞丰富正相关.
乳腺癌和妇科癌的CD47表达区分了免疫热和免疫冷癌,高CD47与免疫治疗和缓解的敏感性增加相关.

结论:

CD47与炎症性TME和免疫热瘤有关.
CD47表达作为一种有价值的生物标志物,用于识别免疫特征.
CD47突出了预测免疫治疗反应和治疗敏感性的潜力.

关键词:

CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 外基因组是外基因组中的一个.妇科癌症妇科癌症免疫治疗是一种免疫疗法.卵巢癌是发生在卵巢中的癌症.

更多相关视频

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...